BMC Pregnancy and Childbirth · 2023 · 14 citations · 12 references
MedicineMaternal HealthObstetricsHigh-risk PregnancyMaternal MortalityMaternal-fetal MedicineCongenital Heart DiseaseMaternal ComplicationsMaternal Medical ConditionsPregnancyPulmonary HypertensionPulmonary Vascular DiseaseHemodynamic Monitoring In PregnancyIdiopathic Pulmonary HypertensionPregnancy In Pulmonary HypertensionPulmonary Artery Pressure MeasurementPulmonary Hypertension Due To Congenital Heart DiseasePulmonary Hypertension Due To Left Heart DiseasePulmonary Hypertension In PregnancySystolic Blood Pressure
BACKGROUND: In recent years, with the development of monitoring conditions and the application of pulmonary vascular-targeted drugs, pregnancy outcomes in women with pulmonary hypertension (PH) have improved, but the maternal mortality rate is still high. The purpose of this study was to describe the maternal-foetal outcomes in pregnant women with PH. METHODS: The clinical data of 154 pregnant women with PH who were admitted to the Third Affiliated Hospital of Guangzhou Medical University from January 2011 to December 2020 were collected and descriptively analysed. RESULTS: Among the 154 pregnant women with PH, 6 (3.9%) had idiopathic pulmonary arterial hypertension (iPAH), 41 (26.6%) had pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD-PAH), 45 (29.2%) had PAH related to other diseases (oPAH), and 62 (40.3%) had PH related to left heart disease (LHD-PH). The systolic pulmonary artery pressure (sPAP) was 36-49 mmHg in 53.2% of the patients, 50-69 mmHg in 22.1% of the patients and ≥ 70 mmHg in 24.7% of the patients. Five (3.2%) pregnant women died within 1 week after delivery; iPAH patients had the highest mortality rate (3/6, 50%). Fifty-four patients (35.1%) were admitted to the intensive care unit (ICU), and the incidence of heart failure during pregnancy was 14.9%. A total of 70.1% of the patients underwent caesarean section; 42.9% had premature infants; 28.6% had low-birth-weight (LBW) infants; 13.0% had very-low-birth-weight (VLBW) infants; 3.2% had extremely-low-birth-weight (ELBW) infants; 61% had small for gestational age (SGA) infants; and 1.9% experienced neonatal mortality. CONCLUSION: There were significant differences in the maternal-foetal outcomes in the iPAH, CHD-PAH, oPAH and LHD-PH groups. Maternal mortality was highest in the iPAH group; therefore, iPAH patients should be advised to prevent pregnancy. Standardized and multidiscipline-assisted maternal management is the key to improving maternal-foetal outcomes.
12
Vera Regitz‐Zagrosek, Carina Blomström Lundqvist, Claudio Borghi et al. · European Heart Journal · 2011 · 1.9K citations · Full text
Medicine, Cardiology, Obstetrics +17
Karen Sliwa, Iris M. van Hagen, Werner Budts et al. · European Journal of Heart Failure · 2016 · 268 citations · Full text
Medicine, Cardiology, Obstetrics +16